40 related articles for article (PubMed ID: 38503153)
1. Resveratrol for inflammatory bowel disease in preclinical studies: a systematic review and meta-analysis.
Gu Y; Lou Y; Zhou Z; Zhao X; Ye X; Wu S; Li H; Ji Y
Front Pharmacol; 2024; 15():1411566. PubMed ID: 38948464
[No Abstract] [Full Text] [Related]
2. Polyphenols and inflammatory bowel disease: Natural products with therapeutic effects?
Vaghari-Tabari M; Alemi F; Zokaei M; Moein S; Qujeq D; Yousefi B; Farzami P; Hosseininasab SS
Crit Rev Food Sci Nutr; 2024; 64(13):4155-4178. PubMed ID: 36345891
[TBL] [Abstract][Full Text] [Related]
3. A nanoemulsified formulation of dolutegravir and epigallocatechin gallate inhibits HIV-1 replication in cellular models.
Gaikwad SY; Tyagi S; Seniya C; More A; Chandane-Tak M; Kumar S; Mukherjee A
FEBS Lett; 2024 May; ():. PubMed ID: 38789398
[TBL] [Abstract][Full Text] [Related]
4. Recent developments and new directions in the use of natural products for the treatment of inflammatory bowel disease.
Feng Y; Pan M; Li R; He W; Chen Y; Xu S; Chen H; Xu H; Lin Y
Phytomedicine; 2024 Jun; 132():155812. PubMed ID: 38905845
[TBL] [Abstract][Full Text] [Related]
5. Bridging the gap: Integrating exercise mimicry into chronic disease management through suppressing chronic inflammation.
Nasb M; Li F; Dayoub L; Wu T; Wei M; Chen N
J Adv Res; 2024 May; ():. PubMed ID: 38704088
[TBL] [Abstract][Full Text] [Related]
6. Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases.
Eng QY; Thanikachalam PV; Ramamurthy S
J Ethnopharmacol; 2018 Jan; 210():296-310. PubMed ID: 28864169
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin-3-gallate and hydroxytyrosol improved antioxidative and anti-inflammatory responses in bovine mammary epithelial cells.
Basiricò L; Morera P; Dipasquale D; Bernini R; Santi L; Romani A; Lacetera N; Bernabucci U
Animal; 2019 Dec; 13(12):2847-2856. PubMed ID: 31182175
[TBL] [Abstract][Full Text] [Related]
8. The potential of EGCG in modulating the oral-gut axis microbiota for treating inflammatory bowel disease.
Ge J; Li M; Yao J; Guo J; Li X; Li G; Han X; Li Z; Liu M; Zhao J
Phytomedicine; 2024 Jul; 130():155643. PubMed ID: 38820660
[TBL] [Abstract][Full Text] [Related]
9. Low dose Epigallocatechin Gallate Alleviates Experimental Colitis by Subduing Inflammatory Cells and Cytokines, and Improving Intestinal Permeability.
Du Y; Ding H; Vanarsa K; Soomro S; Baig S; Hicks J; Mohan C
Nutrients; 2019 Jul; 11(8):. PubMed ID: 31362373
[TBL] [Abstract][Full Text] [Related]
10. Effects of EGCG content in green tea extract on pharmacokinetics, oxidative status and expression of inflammatory and apoptotic genes in the rat ocular tissues.
Chu KO; Chan KP; Yang YP; Qin YJ; Li WY; Chan SO; Wang CC; Pang CP
J Nutr Biochem; 2015 Nov; 26(11):1357-67. PubMed ID: 26362107
[TBL] [Abstract][Full Text] [Related]
11. The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review.
Zhang S; Zhu Q; Chen JY; OuYang D; Lu JH
Phytomedicine; 2020 Dec; 79():153316. PubMed ID: 32942205
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of epigallocatechin-3-gallate for inflammatory bowel disease: A preclinical meta-analysis.
Wei F; Li D; Chen X; Li Y; Zeng Y; Cai Y; Zeng Y; Chen Y; Ma X; Zeng J
Phytomedicine; 2024 Jun; 128():155408. PubMed ID: 38503153
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
